A lay prescription for tailor-made drugs - Focus group reflections on pharmacogenomics

Health Policy

Volumn 71, Issue 2, 2005, Pages 233-241

  Almarsdóttir, Anna Birna ^a   Björnsdóttir, Ingunn ^b   Traulsen, Janine Morgall ^c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b The Pharmaceutical Soc of Iceland   (Iceland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Focus groups; Genetics; Iceland; Lay perspectives; Pharmaceutical R D; Pharmacogenomics

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG COST; DRUG INDUSTRY; FEMALE; HUMAN; HUMAN GENOME; ICELAND; MALE; PHARMACOGENOMICS; POLITICS; PREDICTION; PRESCRIPTION;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AGED; DRUG INDUSTRY; FEMALE; FOCUS GROUPS; HUMANS; ICELAND; MALE; MIDDLE AGED; PHARMACOGENETICS;

EID: 10644251726     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2004.08.010     Document Type: Article

References (30)

1. M. Wortman Medicine gets personal Technology Review 2001 72 78
2. R. March Pharmacogenomics: the genomics of drug response Yeast 17 2000 16 21
3. P.P. Rioux Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications American Journal of Health-System Pharmacy 57 2000 887 901
4. T. Hampton FDA seeks genome-based drug data Journal of the American Medical Association 291 1 2004 32 33
5. D.L. Veenstra, and M.K. Higashi Assessing the cost-effectiveness of pharmacogenomics AAPS Pharmsci 2 3 2000 29
6. P. Danzon, and A. Towse The genomic revolution: is the real risk under-investment rather than bankrupt health care systems? Journal of Health Service Research Policy 5 4 2000 253 255
7. P. Danzon, and A. Towse The economics of gene therapy and pharmacogenetics Value in Health 5 1 2002 5 13
8. K.A. Phillips, D.L. Veenstra, E. Oren, J.K. Lee, and W. Sadee Potential role of pharmacogenomics in reducing adverse drug reactions - a systematic review Journal of the American Medical Association 286 18 2001 2270 2279
9. C.D. Mullins, J. Wang, F.B. Palumbo, and B. Stuart The impact of pipeline drugs on drug spending growth Health Affairs 20 5 2001 210 215
10. C.F. Ard, and M.R.A Natowicz A seat at the table: Membership in Federal Advisory Committees evaluating public policy in genetics American Journal of Public Health 91 5 2001 787 790
11. E.W. Clayton Ethical legal and social implications of genomic medicine New England Journal of Medicine 349 6 2003 562 569
12. A. Petersen The new genetic citizens A. Petersen R. Bunton The new genetics and the public's health 2002 Routledge New York
13. J.L. Bevan, J.A. Lynch, T.N. Dubriwny, T.M. Harris, P.J. Achter, and A.L. Reeder Informed lay preferences for delivery of racially varied pharmacogenomics Genetics in Medicine 5 5 2003 393 399
14. C. Condit, A. Templeton, B.R. Bates, J.L. Bevan, and T.M. Harris Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons Genetics in Medicine 5 5 2003 385 392
15. Anon. The Health Care Database Act 139. Reykjavík: The Ministry of Health and Social Security, 1998.
16. G. Pálsson, and P. Rabinow The Icelandic genome debate Trends in Biotechnology 19 5 2001 166 171
17. G. Pálsson, and K. Harardóttir For whom the cell tolls - debates about biomedicine Current Anthropology 43 2 2002 271 301
18. C. Bowie, A. Richardson, and W. Sykes Consulting the public about priorities British Medical Journal 311 1995 1155 1158
19. J. Kitzinger, and R.S. Barbour Introduction: the challenge and promise of focus groups R.S. Barbour J. Kitzinger Developing focus group research - politics, theory and practice 1999 Sage London
20. J. Kitzinger The methodology of focus groups: the importance of interaction between research participants Sociology of Health and Illness 16 1 1994 103 121
21. C. Waterton, and B. Wynne Can focus groups access community views? R.S. Barbour J. Kitzinger Developing focus group research - politics, theory and practice 1999 Sage London
22. G.Á. Gunnlaugsson Population and migration patterns 1880-1990 G. Hálfdanarson S. Kristjánsson Icelandic societal development 1880-1990: essays (in Icelandic) 1993 University of Iceland Social Science Research Institute Reykjavík
23. Christensen BM, Gunnlaugsson HP. Qualitative Analysis in Windows, Aarhus University Department of Political Science, 1999 (in Danish). http://www.phys.au.dk/∼hpg/Manual1.doc (May 2, 2003).
24. Mayring P. Qualitative Content Analysis [28 paragraphs]. Forum: Qualitative Social Research [on-line Journal] 2000;1(2). Available at: http://www.qualitative-research.net/fqs-texte/2-00/2-00mayring-e.htm [date of access: July 20, 2004].
25. Traulsen JM, Almarsdóttir AB, Björnsdóttir I. Interviewing the moderator, Qualitative Health Research 2004;14(5):714-25.
26. A.M. Issa Ethical perspectives on pharmacogenomic profiling in the drug development process Nature Reviews Drug Discovery 1 4 2002 300 308
27. C. Møldrup When pharmacogenomics goes public New Genetics and Society 21 1 2002 29 37
28. C. Møldrup, J.M. Morgall, and A.B. Almarsdóttir Citizen involement in future drug R&D: a Danish delphi study Foresight 2 5 2000 497 506
29. A.B. Almarsdóttir, J.M. Morgall, and I. Björnsdóttir A question of emphasis: efficiency or equality in the provision of pharmaceuticals International Journal of Health Planning and Management 15 2000 149 161
30. J. Morgall Traulsen, A.B. Almarsdóttir, and I. Björnsdóttir The lay user perspective on the quality of pharmacy services - results of focus group discussions Pharmacy World and Science 24 5 2002 196 200